ClinicalTrials.gg
CompletedNCT05565196Updated Dec 10, 2024

Birth Companion Intervention in Ethiopia, Kenya and Nigeria

An interventional study of Birth companions in Maternal Care Patterns, sponsored by Jhpiego. Completed at 5 sites in 3 countries. Open to female participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-10.

Sponsored by Jhpiego · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
10,360
Allocation
Randomized
Ages
15 Years and older
Sex
Female
01

Study summary

The study aims to assess the acceptability; feasibility; implementation cost; and penetration of the birth companion intervention introduced at health facilities. It is a multi-country study (Ethiopia, Kenya and Nigeria) with a two parallel arm cluster randomized controlled trial design. The study duration will approximately be 16 months.

Read the detailed description

The overall purpose of this study is to investigate how a birth companion (BC) intervention can be implemented to increase the proportion of women who are accompanied by a BC during labor, childbirth, and postpartum in Ethiopia, Kenya and Nigeria. After baseline data collection, facilities will be randomized in a 3:1 ratio; for every three facilities that receive the BC intervention, one facility will serve as a control facility. After randomization, over the course of two months, intervention facilities will start preparing to introduce the BC intervention to facilitate presence of BC during labor and delivery, while the control facilities will continue to provide the local standard of routine care. The intervention will have the following components: 1) Orient facilities and providers to benefits of BC; 2) Develop/update formal standard operating procedures (SOP) for implementing BC and develop plans to implement SOP; 3) Assess data required for implementation and an audit and feedback cycle for tracking coverage; 4) Assess and carry out modest structural changes in facilities to facilitate BC; 5) Use human centered design to develop materials/resources and a means to distinguish/recognize the BC, taking into account common barriers and misconceptions; 6) Prepare providers to integrate BC into care team; 7) Orient antenatal care (ANC) clients to BC rationale and selection; 8) Prepare BCs to support women; 9) Iterate model and track intervention/policies. Investigators will use a mixed methods approach to address the implementation research questions with exit interviews, health facility register data extraction, in-depth interviews, focus group discussions, and key informant interviews. Investigators will collect quarterly quantitative and qualitative data over the course of one week each, for a total of five data collection periods including baseline.

02

Conditions studied

  • Maternal Care Patterns
03

In context

Lead sponsor

Jhpiego is the lead sponsor of 32 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Facilities

  • Prior to randomization, head of facility grants permission for facility to participate in the study
  • Be willing to develop, adopt, and implement the BC standard operating procedures and other components of the BC intervention package
  • Have more than 16 births per month during the past three months
  • Be in the Addis Ababa and surrounding area, Ethiopia, in Muranga and Machakos County, Kenya or Nasarawa and Kano states, Nigeria

Providers

  • At the time of enrollment, providers need to work in ANC or labor and delivery ward(s) of the study facilities
  • Able and willing to provide to participate in the study

Mothers

  • Per participant report, age 15 years or older
  • Have vaginal birth
  • Able and willing to provide informed consent to participate in the study

Birth companions

  • Per participant report, for emancipated minors, age 15 years or older. If not an emancipated minor, per participant report, 18 years or older
  • Was present at labor and/or delivery
  • Identified as a BC by the delivering mother
  • Able and willing to provide informed consent to participate in the study

Unit managers

  • Involved in the implementation and management of the BC intervention
  • Able and willing to provide informed consent to participate in the study

Exclusion criteria

Exclusion Criteria:

Facilities

  • Facility staff strike or other disturbance to routine care noted prior to randomization that would pose significant challenge(s) to achieving the study objectives

Providers

  • N/A

Mothers

  • Unable to participate in an interview due to their physical or emotional condition caused by an adverse delivery outcome.
  • Unable to provide valid information because of mental or other serious health condition

Birth companions

  • Unable to provide valid information because of mental or other serious health condition

Unit managers

  • N/A
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
10,360 participants (actual)

Study arms

  • Experimental
    Birth companion intervention arm

    Women who deliver in facilities in the experimental arm will be exposed to a facility-based intervention designed to improve companionship in labor, childbirth, and postpartum periods.

    Behavioral: Birth companions

  • No intervention
    Standard of care arm

    Women who deliver in facilities in the experimental arm will be exposed to the standard of care for labor, delivery, and the postpartum period.

Interventions

  • BehavioralBirth companions

    The intervention will have the following components: 1) Orient facilities and providers to benefits of BC; 2) Develop/update formal standard operating procedures (SOP) for implementing BC and develop plans to implement SOP; 3) Assess data required for implementation and an audit and feedback cycle for tracking coverage; 4) Assess and carry out modest structural changes in facilities to facilitate BC; 5) Use human centered design to develop materials/resources and a means to distinguish/recognize the BC, taking into account common barriers and misconceptions; 6) Prepare providers to integrate BC into care team; 7) Orient ANC clients to BC rationale and selection; 8) Prepare BCs to support women; 9) Iterate model and track intervention/policies.

06

What researchers measure

Primary outcomes

  1. Change in Birth Companion Coverage

    Between baseline and endline surveys, the investigators will measure the change in the proportion of women who are accompanied by a birth companion during labor, childbirth, and postpartum.

    Time frame: Between baseline and Endline survey (12 months after intervention is initiated).

Secondary outcomes

  1. Choice of Birth Companion

    Between baseline and endline surveys, among women who report having a birth companion, the investigators will measure the change in the proportion who report that their birth companion was the one of their choice.

    Time frame: Between baseline and Endline survey (12 months after intervention is initiated).

  2. Change in Experience of Care (Mothers'-Quantitative)

    Between baseline and endline surveys, the investigators will measure the change in mothers' score on Person-Centered Maternity Care scale. This scale has 33 items with a score ranging from 0-98. A low score signifies a better outcome.

    Time frame: Between baseline and Endline survey (12 months after intervention is initiated).

  3. Experience of Care (Mothers'-Qualitative)

    In intervention facilities, among women who had birth companions investigators will use in-depth interviews to explore their perception of having a birth companion.

    Time frame: Quarterly after initiation of the intervention (for a period of 12 months).

  4. Feasibility (Unit managers and Providers-Quantitative)

    In intervention facilities, investigators will measure the proportion of providers and unit managers who report the physical environment of care supports the presence of birth companions during labor, birth, and the postnatal period.

    Time frame: Endline survey (12 months after intervention is initiated).

  5. Feasibility (Unit Managers-Qualitative)

    In intervention facilities, investigators will use key informant interviews to understand unit managers' perception on the feasibility of having birth companions.

    Time frame: Quarterly after the initiation of the intervention (for a period of 12 months).

  6. Acceptability (Mothers)

    In intervention facilities, investigators will use in-depth interviews to understand mothers' perception on the acceptability of having birth companions.

    Time frame: Quarterly after the initiation of the intervention (for a period of 12 months).

  7. Acceptability (Birth Companions)

    In intervention facilities, investigators will use in-depth interviews to understand birth companions' perception on the acceptability of being a birth companion.

    Time frame: Quarterly after the initiation of the intervention (for a period of 12 months).

  8. Acceptability (Providers)

    In intervention facilities, investigators will use focus group discussions to understand providers' perception on the acceptability of having birth companions.

    Time frame: Quarterly after the initiation of the intervention (for a period of 12 months).

  9. Acceptability (Unit Managers)

    In intervention facilities, investigators will use qualitative methods understand unit managers' perception on the acceptability of having birth companions.

    Time frame: Quarterly after the initiation of the intervention (for a period of 12 months).

Other outcomes

  1. Potential association between baseline facility readiness and intervention coverage

    In intervention facilities, investigators will measure score on facility readiness to change (at baseline) to explore potential association with coverage of the intervention at endline. The tool used for facility staff has scale with 19 items and the score ranges from 0 to 57. The tool used for facility leaders has a scale with 34 items and a score ranging from 0 to 100. Low score means better outcome.

    Time frame: Endline survey (12 months after intervention is initiated)

  2. Cost

    In intervention facilities investigators will collect data on facility-level costs for updates to physical environment of care and other implementation costs.

    Time frame: Endline survey (12 months after intervention is initiated)

07

Study locations

5 sites
  • Saint Paul's Millennium College
    Addis Ababa, Ethiopia
  • Machakos County Health Office
    Machakos, Kenya
  • Murang'a County Health Office
    Murang'a, Kenya
  • Kano State Health Office
    Kano, Nigeria
  • Nasarawa Sate Health Office
    Karu, Nigeria
08

References and documents

Individual participant data

Plan to share: No — Per current Bill \& Melinda Gates Foundation policy for study data

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05565196
Lead sponsor
Jhpiego
Collaborators
Addis Continental Institute of Public Health, St Paul's Hospital Millennium Medical College, International Center for Reproductive Health Kenya, Bill and Melinda Gates Foundation, Maternal and Reproductive Health Research Collective
Responsible party
Della Berhanu (Research lead, Jhpiego) — Principal investigator
First posted
Oct 4, 2022
Start date
Oct 10, 2022
Primary completion
Nov 18, 2024
Completion
Nov 18, 2024
Last update
Dec 10, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion